Specificity in the binding of aminoglycosides to HIV-RRE RNA.
Quantitative studies of the binding of neomycin B to RRE constructs are carried out to determine the relationship between non-Watson Crick base-paired elements in the RNA and aminoglycoside binding. The RRE region contains two unpaired domains containing a single base bulge and a bubble structure, respectively. Deletion of the single base bulge has no effect on neomycin binding as the site of aminoglycoside binding is localized to the bubble region. Converting the bubble region into an A-form duplex gradually abolishes neomycin B binding in 3-5-fold steps in affinity over a 75-fold range. Thus, the binding of aminoglycoside is favored at domains in RNA that are nonduplex in nature, but aminoglycoside binding is only graded-specific in that affinities are enhanced gradually as the structure further deviates from a duplex form. It is likely that high-affinity aminoglycoside binding does not occur in duplex RNA because the major groove is too narrow to allow for aminoglycoside access and that structural perturbations that allow widening of the groove facilitate access. However, these interactions are only graded-specific with respect to both aminoglycoside structure and RNA domain structure.
Cho
J
J
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Rando
R R
RR
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000378:metabolism*; D001665:Binding Sites; D004252:DNA Mutational Analysis; D005456:Fluorescent Dyes / Q000378:metabolism; D005601:Framycetin / Q000737:chemistry / Q000378:metabolism; D015694:Gene Products, rev / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D006678:HIV / Q000737:chemistry / Q000235:genetics*; D010303:Paromomycin / Q000737:chemistry / Q000378:metabolism; D012367:RNA, Viral / Q000737:chemistry / Q000378:metabolism*; D020218:Response Elements; D012235:Rhodamines / Q000378:metabolism; D054321:rev Gene Products, Human Immunodeficiency Virus
C114557:5-carboxytetramethylrhodamine succinimidyl ester; D000900:Anti-Bacterial Agents; D005456:Fluorescent Dyes; D015694:Gene Products, rev; D012367:RNA, Viral; D012235:Rhodamines; D054321:rev Gene Products, Human Immunodeficiency Virus; D005601:Framycetin; D010303:Paromomycin